• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期调控因子在肺癌发生中的作用。

Role of cell cycle regulators in lung carcinogenesis.

机构信息

Equipe Bases Moléculaires de la Progression des Cancers du Poumon, Centre de Recherche INSERM U823, Institut Albert Bonniot, Grenoble, France; Université Joseph Fourier, Grenoble, France.

出版信息

Cell Adh Migr. 2010 Jan-Mar;4(1):114-23. doi: 10.4161/cam.4.1.10977. Epub 2010 Jan 16.

DOI:10.4161/cam.4.1.10977
PMID:20139697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2852568/
Abstract

Cellular division is an ordered, tightly regulated process involving multiple checkpoints that assess extracellular growth signals, cell size and DNA integrity. Progression throughout the cell cycle is based on the activation of different CDK-cyclin complexes that prevent cells from entering into a new phase until thay have successfully complete the previous one. In addition, a series of cell cycle checkpoints are designed to preserve genome integrity and chromosomal stability. Neoplastic lung cells develop the ability to bypass several of these checkpoints, and tumor cell proliferation is frequently associated with genetic or epigenetic alterations in key regulators of the cell cycle. The goal of this review is to summarize the knowledge about the dysregulation of major cell cycle regulators in lung cancer pathogenesis and to discuss the use of these proteins as targets for therapeutic intervention.

摘要

细胞分裂是一个有序且受到严格调控的过程,涉及多个检查点,用于评估细胞外生长信号、细胞大小和 DNA 完整性。细胞周期的进展基于不同 CDK-cyclin 复合物的激活,这些复合物可防止细胞进入新的阶段,直到成功完成前一个阶段。此外,还设计了一系列细胞周期检查点来保护基因组完整性和染色体稳定性。肿瘤肺细胞具有绕过这些检查点的能力,而肿瘤细胞的增殖通常与细胞周期关键调节因子的遗传或表观遗传改变有关。本综述的目的是总结肺癌发病机制中主要细胞周期调节剂失调的知识,并讨论将这些蛋白作为治疗干预的靶点。

相似文献

1
Role of cell cycle regulators in lung carcinogenesis.细胞周期调控因子在肺癌发生中的作用。
Cell Adh Migr. 2010 Jan-Mar;4(1):114-23. doi: 10.4161/cam.4.1.10977. Epub 2010 Jan 16.
2
Cell cycle and cancer.细胞周期与癌症。
J Biochem Mol Biol. 2003 Jan 31;36(1):60-5. doi: 10.5483/bmbrep.2003.36.1.060.
3
Current concepts in neuro-oncology: the cell cycle--a review.神经肿瘤学的当前概念:细胞周期——综述
Neurosurgery. 1997 May;40(5):1000-13; discussion 1013-5. doi: 10.1097/00006123-199705000-00025.
4
Cell cycle regulation and its aberrations in human lung carcinoma.人类肺癌中的细胞周期调控及其异常
Pathol Int. 2005 Mar;55(3):95-105. doi: 10.1111/j.1440-1827.2005.01799.x.
5
Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.与可切除肿瘤相比,晚期非小细胞肺癌中细胞周期调节因子的改变频率较低。
Lung Cancer. 2001 Aug-Sep;33(2-3):229-39. doi: 10.1016/s0169-5002(01)00196-9.
6
Checking out the G(2)/M transition.检查G(2)/M转换。
Biochim Biophys Acta. 2001 May 28;1519(1-2):1-12. doi: 10.1016/s0167-4781(01)00204-4.
7
Progressive derailment of cell cycle regulators in endometrial carcinogenesis.子宫内膜癌发生过程中细胞周期调节因子的渐进性失调。
J Clin Pathol. 2008 Jan;61(1):36-42. doi: 10.1136/jcp.2006.043794. Epub 2007 May 4.
8
Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.G1期细胞周期蛋白依赖性激酶调控与转化生长因子-β介导的细胞周期调控
Adv Cancer Res. 1997;71:165-207. doi: 10.1016/s0065-230x(08)60099-8.
9
Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.小鼠乳腺肿瘤前期早期阶段的细胞周期蛋白依赖性激酶(cdk)抑制剂/cdk4/cdk2复合物
Cell Growth Differ. 2001 Jun;12(6):285-95.
10
GPx3-mediated redox signaling arrests the cell cycle and acts as a tumor suppressor in lung cancer cell lines.谷胱甘肽过氧化物酶 3 介导的氧化还原信号抑制细胞周期并在肺癌细胞系中作为肿瘤抑制因子发挥作用。
PLoS One. 2018 Sep 27;13(9):e0204170. doi: 10.1371/journal.pone.0204170. eCollection 2018.

引用本文的文献

1
Molecular signatures bidirectionally link myocardial infarction and lung cancer.分子特征双向连接心肌梗死和肺癌。
Front Med (Lausanne). 2025 Apr 9;12:1576375. doi: 10.3389/fmed.2025.1576375. eCollection 2025.
2
An Overview of the Bioactivity of Spontaneous Medicinal Plants Suitable for the Improvement of Lung Cancer Therapies.适用于改善肺癌治疗的天然药用植物生物活性概述
Pharmaceutics. 2025 Mar 5;17(3):336. doi: 10.3390/pharmaceutics17030336.
3
The potential of the South African plant Tulbaghia Violacea Harv for the treatment of triple negative breast cancer.南非植物紫花垂笑君子兰治疗三阴性乳腺癌的潜力。
Sci Rep. 2025 Feb 17;15(1):5737. doi: 10.1038/s41598-025-88417-2.
4
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer.细胞周期蛋白依赖性激酶4/6(CDK4/6)抑制剂可促进聚(ADP-核糖)聚合酶1(PARP1)降解,并在非小细胞肺癌中与PARP抑制剂发挥协同作用。
Transl Oncol. 2025 Feb;52:102231. doi: 10.1016/j.tranon.2024.102231. Epub 2024 Dec 10.
5
Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells.脱氧博伐他汀通过靶向 EGFR、MET 和 AKT 信号通路抑制非小细胞肺癌细胞。
Sci Rep. 2024 Sep 6;14(1):20820. doi: 10.1038/s41598-024-70823-7.
6
Cross-attention enables deep learning on limited omics-imaging-clinical data of 130 lung cancer patients.跨注意力使深度学习能够利用 130 名肺癌患者的有限组学-影像-临床数据。
Cell Rep Methods. 2024 Jul 15;4(7):100817. doi: 10.1016/j.crmeth.2024.100817. Epub 2024 Jul 8.
7
Identification of a methyltransferase-related long noncoding RNA signature as a novel prognosis biomarker for lung adenocarcinoma.鉴定一个与甲基转移酶相关的长非编码 RNA 特征作为肺腺癌的新型预后生物标志物。
Aging (Albany NY). 2024 May 20;16(10):8747-8771. doi: 10.18632/aging.205837.
8
Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma.基于全切片图像的替代生物标志物预测在评估肺腺癌总生存中的应用
Diagnostics (Basel). 2024 Feb 20;14(5):462. doi: 10.3390/diagnostics14050462.
9
Vitamin D3 promotes gastric cancer cell autophagy by mediating p53/AMPK/mTOR signaling.维生素D3通过介导p53/AMPK/mTOR信号通路促进胃癌细胞自噬。
Front Pharmacol. 2024 Jan 8;14:1338260. doi: 10.3389/fphar.2023.1338260. eCollection 2023.
10
Application of codon usage and context analysis in genes up- or down-regulated in neurodegeneration and cancer to combat comorbidities.密码子使用和上下文分析在神经退行性疾病和癌症中上调或下调基因中的应用以对抗共病。
Front Mol Neurosci. 2023 Jun 13;16:1200523. doi: 10.3389/fnmol.2023.1200523. eCollection 2023.

本文引用的文献

1
Emerging roles of E2Fs in cancer: an exit from cell cycle control.E2F蛋白在癌症中的新作用:从细胞周期调控中脱离
Nat Rev Cancer. 2009 Nov;9(11):785-97. doi: 10.1038/nrc2696.
2
Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.细胞周期蛋白B1和细胞周期蛋白A在非小细胞肺癌中的表达及预后意义
Histopathology. 2009 Jul;55(1):28-36. doi: 10.1111/j.1365-2559.2009.03331.x.
3
Cell cycle kinases as therapeutic targets for cancer.细胞周期激酶作为癌症的治疗靶点。
Nat Rev Drug Discov. 2009 Jul;8(7):547-66. doi: 10.1038/nrd2907.
4
Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.I-IIIA期切除的非小细胞肺癌中细胞周期蛋白A和细胞周期蛋白E的表达
In Vivo. 2009 Jul-Aug;23(4):519-25.
5
Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features.非小细胞肺癌中检查点激酶2基因的表观遗传失活及其与临床病理特征的关系。
Lung Cancer. 2009 Aug;65(2):247-50. doi: 10.1016/j.lungcan.2009.03.011. Epub 2009 Apr 11.
6
Polo-like kinases: conservation and divergence in their functions and regulation.Polo样激酶:其功能与调控的保守性与差异性
Nat Rev Mol Cell Biol. 2009 Apr;10(4):265-75. doi: 10.1038/nrm2653.
7
The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.小分子细胞周期蛋白依赖性激酶(CDK)抑制剂SNS-032可增强静止和缺氧的非小细胞肺癌细胞的细胞放射敏感性。
Lung Cancer. 2009 Oct;66(1):37-47. doi: 10.1016/j.lungcan.2008.12.026. Epub 2009 Feb 3.
8
Telomere length, telomeric proteins and DNA damage repair proteins are differentially expressed between primary lung tumors and their adrenal metastases.端粒长度、端粒蛋白和DNA损伤修复蛋白在原发性肺肿瘤及其肾上腺转移瘤之间存在差异表达。
Lung Cancer. 2009 Aug;65(2):144-9. doi: 10.1016/j.lungcan.2008.10.030. Epub 2008 Dec 16.
9
Somatic mutations affect key pathways in lung adenocarcinoma.体细胞突变影响肺腺癌的关键通路。
Nature. 2008 Oct 23;455(7216):1069-75. doi: 10.1038/nature07423.
10
Statistical issues in translational cancer research.转化癌症研究中的统计学问题。
Clin Cancer Res. 2008 Oct 1;14(19):5954-8. doi: 10.1158/1078-0432.CCR-07-4537.